# Cost-effectiveness of HPV vaccination for girls in Venezuela

Source: https://onco.cc/key-papers/paper-bardach-hpv-vaccine-cea-venezuela-bmcph-2017/  
OnCo record `paper-bardach-hpv-vaccine-cea-venezuela-bmcph-2017` (Key paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A Markov model of a cohort of 264,489 Venezuelan 11-year-old girls found the bivalent and quadrivalent HPV vaccines cost-saving compared with screening alone in all scenarios tested.

## Summary

Published as "Health economic evaluation of Human Papillomavirus vaccines in women from Venezuela by a lifetime Markov cohort model". Authors from the Instituto de Efectividad Clínica y Sanitaria in Buenos Aires, Venezuelan public health researchers and two authors from GSK adapted a published model to Venezuela from the health payer's perspective, discounting costs and QALYs at 5%.

## Fields

- Kind: Key paper
- Last checked: 2026-11-11
- Journal: BMC Public Health
- Year: 2017
- DOI: 10.1186/s12889-017-4064-7
- Authors: Bardach AE, Garay OU, Calderón M, et al.
- Findings: Compared with screening only, the bivalent and quadrivalent vaccines were cost-saving in all eight scenarios, avoiding 2,310 and 2,143 deaths and 4,781 and 4,431 cervical cancers respectively.; They gained 4,486 and 4,395 discounted QALYs; neither vaccine was consistently more cost-effective than the other.
- What it means: Economic evidence for adding HPV vaccine to Venezuela's schedule; WHO's immunisation data still recorded the vaccine as not introduced nationally in 2025.
- Caveats: GSK, which makes the bivalent vaccine, funded the study, and two authors were GSK employees.; Prices and exchange rates in Venezuela have changed greatly since the model was built.

## Sources

- BMC Public Health 2017: https://doi.org/10.1186/s12889-017-4064-7
- PubMed: https://pubmed.ncbi.nlm.nih.gov/28148228/

## Connected records

- cancers: [Cervical cancer](https://onco.cc/cancers/cervical/)
- technologies: [HPV & HBV vaccination](https://onco.cc/technologies/hpv-vaccine/)
- institutions: [Ministerio del Poder Popular para la Salud (Venezuela)](https://onco.cc/institutions/venezuela-ministry-of-health/)

---
JSON: https://onco.cc/api/v1/entities/paper-bardach-hpv-vaccine-cea-venezuela-bmcph-2017.json